Imperva Inc (NYSE:IMPV) was downgraded by investment analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a research report issued on Wednesday.

Several other brokerages have also recently issued reports on IMPV. Evercore ISI reaffirmed a “buy” rating and issued a $56.00 price objective on shares of Imperva in a research note on Monday, May 15th. Monness Crespi & Hardt initiated coverage on shares of Imperva in a research note on Tuesday, March 14th. They issued a “buy” rating and a $52.00 price objective on the stock. Zacks Investment Research cut shares of Imperva from a “buy” rating to a “hold” rating in a research note on Tuesday, May 9th. DA Davidson reaffirmed a “buy” rating and issued a $55.00 price objective on shares of Imperva in a research note on Wednesday, March 22nd. Finally, Susquehanna Bancshares Inc initiated coverage on shares of Imperva in a research note on Wednesday, June 7th. They issued a “positive” rating and a $60.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and eleven have assigned a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $49.03.

Shares of Imperva (NYSE IMPV) traded up 1.07% on Wednesday, reaching $47.05. 319,424 shares of the company’s stock traded hands. The firm’s market capitalization is $1.57 billion. Imperva has a 52 week low of $34.40 and a 52 week high of $57.24. The company has a 50 day moving average price of $49.16 and a 200 day moving average price of $43.54.

Imperva (NYSE:IMPV) last announced its quarterly earnings data on Thursday, May 4th. The software maker reported ($0.29) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.62) by $0.33. The company had revenue of $72.31 million for the quarter, compared to analysts’ expectations of $68.16 million. Imperva had a net margin of 31.92% and a return on equity of 36.67%. The business’s revenue was up 21.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.25) EPS. On average, equities research analysts predict that Imperva will post $0.45 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This piece of content was reported by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2017/07/05/imperva-inc-nyseimpv-cut-to-buy-at-bidaskclub.html.

In other Imperva news, SVP Sunil D. Nagdev sold 4,857 shares of Imperva stock in a transaction that occurred on Tuesday, May 16th. The shares were sold at an average price of $49.00, for a total value of $237,993.00. Following the completion of the sale, the senior vice president now directly owns 16,290 shares in the company, valued at $798,210. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Amichai Shulman sold 3,085 shares of Imperva stock in a transaction that occurred on Monday, April 17th. The shares were sold at an average price of $41.97, for a total transaction of $129,477.45. Following the completion of the sale, the insider now owns 99,151 shares of the company’s stock, valued at $4,161,367.47. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 63,387 shares of company stock valued at $3,005,338. 2.20% of the stock is currently owned by corporate insiders.

A number of hedge funds have recently bought and sold shares of the stock. North Run Capital LP boosted its stake in Imperva by 999.3% in the first quarter. North Run Capital LP now owns 750,000 shares of the software maker’s stock worth $30,788,000 after buying an additional 681,772 shares during the period. Clearbridge Investments LLC boosted its stake in Imperva by 47.0% in the first quarter. Clearbridge Investments LLC now owns 1,262,507 shares of the software maker’s stock worth $51,826,000 after buying an additional 403,809 shares during the period. BNP Paribas Arbitrage SA boosted its stake in Imperva by 8,392.3% in the first quarter. BNP Paribas Arbitrage SA now owns 200,927 shares of the software maker’s stock worth $8,248,000 after buying an additional 198,561 shares during the period. Caisse DE Depot ET Placement DU Quebec acquired a new stake in Imperva during the first quarter worth about $7,192,000. Finally, Bank of Nova Scotia acquired a new stake in Imperva during the first quarter worth about $7,184,000. Hedge funds and other institutional investors own 92.72% of the company’s stock.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Analyst Recommendations for Imperva (NYSE:IMPV)

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.